MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment.
Saved in:
| Title: | MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment. |
|---|---|
| Authors: | Nakashoji A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Bhattacharya A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Ozawa H; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Haratake N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Shigeta K; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Fushimi A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Yamashita N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Matsui A; Department of Breast Surgery, National Hospital Organization Tokyo Medical Center, Tokyo, Japan., Kure S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Kameyama T; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Takeuchi M; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Fukuda K; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Yokoe T; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Nagayama A; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Hayahsida T; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Kitagawa Y; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Liu R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Giordano A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Jeselsohn R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Shapiro GI; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Kufe D; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Donald_Kufe@dfci.harvard.edu. |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2025 Apr 26; Vol. 11 (1), pp. 39. Date of Electronic Publication: 2025 Apr 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2374-4677 |
|---|---|
| DOI: | 10.1038/s41523-025-00751-w |
